Cargando…

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis

BACKGROUND: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may coexist with rheumatoid arthritis (RA). However, it is unclear whether the manifestations of AAV with and without coexisting RA are similar. This observational study aimed to investigate the clinicopathological m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Haiting, Lu, Yiyun, Hu, Rongrong, Ye, Wei, Wen, Yubing, Cai, Jianfang, Li, Hang, Li, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026933/
https://www.ncbi.nlm.nih.gov/pubmed/35459111
http://dx.doi.org/10.1186/s12882-022-02788-6
_version_ 1784691235096625152
author Wu, Haiting
Lu, Yiyun
Hu, Rongrong
Ye, Wei
Wen, Yubing
Cai, Jianfang
Li, Hang
Li, Xuemei
author_facet Wu, Haiting
Lu, Yiyun
Hu, Rongrong
Ye, Wei
Wen, Yubing
Cai, Jianfang
Li, Hang
Li, Xuemei
author_sort Wu, Haiting
collection PubMed
description BACKGROUND: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may coexist with rheumatoid arthritis (RA). However, it is unclear whether the manifestations of AAV with and without coexisting RA are similar. This observational study aimed to investigate the clinicopathological manifestations of AAV with coexisting RA and to explore potential predictors for identifying AAV superimposed on RA. METHODS: Patients with both AAV and RA were identified by searching our hospital database and the literature. Data including age, sex, clinical manifestation, laboratory tests, renal pathology, and therapeutic regimens were retrieved. To assess the difference in clinical features and renal pathology between AAV patients with and without RA, we conducted 1:4 matched case-control studies. RESULTS: A total of 47 patients were identified, 15 from our hospital and 32 from the literature, and 33 (70.2%) were women. AAV was diagnosed later than RA in 83.0% of the patients and manifested as microscopic polyangiitis (MPA) in 78.7% of the patients. The kidney was the most frequently involved extra-articular organ (74.5%), followed by the lung (51.1%), and skin (8.5%). Patients with both AAV and RA were more likely to be asymptomatic (26.7% vs 3.3%, p = 0.013) than those with isolated AAV. However, they did not differ in other clinicopathological features. In RA patients, those with ANCA associated glomerulonephritis, were more likely to have decreased renal function at renal biopsy as opposed to those with primary glomerulonephritis. CONCLUSIONS: AAV can coexist with RA. In this coexistence, AAV usually develops after RA, is more likely to be asymptomatic, and manifests predominately as MPA with renal involvement. Thus, we should remain vigilant to superimposed AAV on RA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02788-6.
format Online
Article
Text
id pubmed-9026933
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90269332022-04-23 Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis Wu, Haiting Lu, Yiyun Hu, Rongrong Ye, Wei Wen, Yubing Cai, Jianfang Li, Hang Li, Xuemei BMC Nephrol Research Article BACKGROUND: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may coexist with rheumatoid arthritis (RA). However, it is unclear whether the manifestations of AAV with and without coexisting RA are similar. This observational study aimed to investigate the clinicopathological manifestations of AAV with coexisting RA and to explore potential predictors for identifying AAV superimposed on RA. METHODS: Patients with both AAV and RA were identified by searching our hospital database and the literature. Data including age, sex, clinical manifestation, laboratory tests, renal pathology, and therapeutic regimens were retrieved. To assess the difference in clinical features and renal pathology between AAV patients with and without RA, we conducted 1:4 matched case-control studies. RESULTS: A total of 47 patients were identified, 15 from our hospital and 32 from the literature, and 33 (70.2%) were women. AAV was diagnosed later than RA in 83.0% of the patients and manifested as microscopic polyangiitis (MPA) in 78.7% of the patients. The kidney was the most frequently involved extra-articular organ (74.5%), followed by the lung (51.1%), and skin (8.5%). Patients with both AAV and RA were more likely to be asymptomatic (26.7% vs 3.3%, p = 0.013) than those with isolated AAV. However, they did not differ in other clinicopathological features. In RA patients, those with ANCA associated glomerulonephritis, were more likely to have decreased renal function at renal biopsy as opposed to those with primary glomerulonephritis. CONCLUSIONS: AAV can coexist with RA. In this coexistence, AAV usually develops after RA, is more likely to be asymptomatic, and manifests predominately as MPA with renal involvement. Thus, we should remain vigilant to superimposed AAV on RA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02788-6. BioMed Central 2022-04-22 /pmc/articles/PMC9026933/ /pubmed/35459111 http://dx.doi.org/10.1186/s12882-022-02788-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wu, Haiting
Lu, Yiyun
Hu, Rongrong
Ye, Wei
Wen, Yubing
Cai, Jianfang
Li, Hang
Li, Xuemei
Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
title Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
title_full Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
title_fullStr Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
title_full_unstemmed Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
title_short Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
title_sort anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026933/
https://www.ncbi.nlm.nih.gov/pubmed/35459111
http://dx.doi.org/10.1186/s12882-022-02788-6
work_keys_str_mv AT wuhaiting antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT luyiyun antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT hurongrong antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT yewei antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT wenyubing antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT caijianfang antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT lihang antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis
AT lixuemei antineutrophilcytoplasmicantibodyassociatedvasculitisinpatientswithrheumatoidarthritis